6FDA Market Size, Share & Trends Analysis Report By Product (≥ 99.5%, ＜ 99.5%), By Applications (Fluorinated Polyimides, Other), By End Use, By Region, and Segment Forecasts - 2035

6FDA Market Overview

The 6fda market size is expected to grow from USD 57.03 million in 2025 to USD 60.22 million in 2026 and is forecast to reach USD 99.49 million by 2035 at 5.6% CAGR over 2026-2035.

The 6FDA market is expanding as high-performance fluorinated polymers gain importance across advanced electronics, flexible displays, semiconductor materials, gas-separation technologies, specialty coatings, and other technically demanding applications. The ≥ 99.5% product segment represents an estimated 74% of current demand because fluorinated polyimide manufacturing requires tightly controlled purity, low ionic contamination, and consistent monomer characteristics. The ＜ 99.5% segment accounts for approximately 26%, serving applications with comparatively broader material specifications. Fluorinated Polyimides dominates application demand with an estimated 82% share, while Other applications contribute approximately 18%. Asia-Pacific represents approximately 58% of global demand because China, Japan, South Korea, and other regional manufacturing centers have substantial electronics, semiconductor, display-material, and advanced-polymer production capabilities. Demand is increasingly shifting toward electronic-grade 6FDA with purity reaching 99.9% in specialized commercial offerings, reflecting tighter material requirements. Approximately 44% of major development activity is concentrated on improving purity, reducing metal-ion contamination, and strengthening batch consistency as customers seek better dielectric performance, transparency, thermal resistance, and polymer-processing stability.

The United States accounts for an estimated 17% of worldwide 6FDA demand and remains an important market for advanced polymer research, semiconductor materials, specialty membranes, aerospace materials, and high-performance electronics. The ≥ 99.5% segment represents approximately 78% of U.S. consumption because sophisticated applications increasingly require highly controlled chemical composition and very low impurity levels. Fluorinated Polyimides contributes approximately 84% of domestic application demand, while Other applications account for around 16%. Demand is supported by continued investment in microelectronics, high-frequency devices, flexible electronic components, advanced membranes, and specialty polymer systems requiring low dielectric characteristics and strong thermal stability. Approximately 39% of U.S. application-development programs involving fluorinated polyimides are focused on improving dielectric, optical, or heat-resistant performance. Supply security is also becoming more important because 6FDA manufacturing remains concentrated among a relatively small number of specialized producers. Around 36% of high-performance polymer buyers are increasing supplier qualification or dual-sourcing activity to reduce dependence on individual production locations.

• 

  Download Free sample to learn more about this report.

Key Findings

• Leading Product Type: ≥ 99.5% is expected to dominate product demand with approximately 74% market share as Fluorinated Polyimides increasingly require tightly controlled purity, low contamination, and consistent monomer performance.
• Leading Application: Fluorinated Polyimides is projected to account for approximately 82% of demand, supported by expanding requirements for transparent, thermally stable, low-dielectric, and high-performance polymer materials.
• Leading Region: Asia-Pacific leads the global 6FDA market with approximately 58% share, reflecting its concentrated electronics, semiconductor, advanced materials, and high-performance polymer manufacturing infrastructure.
• Fastest Growing Region: Asia-Pacific is expected to remain the fastest-growing region, with specialty fluorinated polymer capacity expanding by approximately 29% across key advanced-material manufacturing clusters.
• Technology Trend: Ultra-high-purity processing is becoming increasingly important, with approximately 44% of major development programs prioritizing lower metal-ion contamination, tighter specifications, and improved monomer consistency.
• Market Driver: Advanced electronics remain a major demand catalyst, with approximately 41% of fluorinated polyimide development activity targeting improved transparency, dielectric characteristics, flexibility, or high-temperature performance.
• Competitive Landscape: The supplied five-company competitive group represents an estimated 71% of market participation, reflecting relatively concentrated production capabilities and significant technical barriers surrounding purification and specialty monomer manufacturing.
• Future Outlook: Application diversification will strengthen long-term demand, with approximately 32% of current development programs examining next-generation membranes, thermal materials, electronic components, and other specialized fluorinated polymer applications.

Latest Trends

Ultra-high-purity 6FDA is becoming increasingly important as semiconductor, electronics, and advanced-polymer customers tighten specifications for metal ions, residual impurities, moisture, and batch consistency. The ≥ 99.5% segment currently accounts for approximately 74% of market demand, while some specialized commercial grades reach 99.9% purity for electronic and advanced polymer applications. Approximately 44% of major product-development activity is concentrated on higher purification efficiency, contamination control, and tighter manufacturing specifications. Fluorinated Polyimides represents approximately 82% of demand because the 6FDA molecular structure helps manufacturers develop polymers with attractive combinations of transparency, thermal stability, solubility, dielectric behavior, and gas-permeation characteristics. Around 41% of advanced fluorinated polyimide development programs are associated with electronic, optical, flexible-display, or high-frequency material requirements. As electronic devices become thinner and more performance-intensive, monomer consistency becomes more critical because relatively small variations in polymer precursor quality can influence final film properties. This trend favors specialized producers capable of delivering electronic-grade material with rigorous quality control.

Application diversification beyond conventional fluorinated polyimide films is also strengthening the industry's technology pipeline. Approximately 32% of development programs are examining advanced separation membranes, specialty coatings, thermal-management structures, insulation materials, and other high-performance fluorinated polymers. Gas-separation research is receiving particular attention because 6FDA-based polyimide structures can combine relatively high permeability with useful selectivity depending on the diamine and polymer architecture used. Flexible and transparent electronics represent another important development area as manufacturers seek materials capable of maintaining optical performance while tolerating repeated mechanical deformation and elevated processing temperatures. Asia-Pacific accounts for approximately 58% of global market demand and is at the center of much of this activity because of its extensive semiconductor, display, and specialty-chemical manufacturing ecosystem. Approximately 29% expansion in specialized fluorinated polymer capacity across selected Asian production clusters is increasing regional demand for high-purity monomers. These trends are moving 6FDA from a narrowly specialized chemical intermediate toward a strategically important precursor within several advanced-material platforms.

Market Dynamics

Driver

""Expanding high-performance fluorinated polyimide applications support sustained demand.""

The primary driver for the 6FDA market is growing consumption of fluorinated polyimides in advanced materials requiring thermal stability, optical clarity, flexibility, low dielectric performance, and chemical resistance. Fluorinated Polyimides accounts for approximately 82% of total application demand, making developments within this polymer family the strongest influence on 6FDA consumption. The ≥ 99.5% grade represents approximately 74% of product demand because advanced polymerization processes increasingly require highly consistent monomer quality. Around 41% of fluorinated polyimide development activity is associated with electronics, optical materials, flexible devices, or high-frequency applications. Semiconductor and advanced-display manufacturing are particularly important because materials used close to sensitive electronic components must maintain stable electrical and thermal characteristics. Continued miniaturization, flexible-device development, and demand for higher processing temperatures are expected to support greater consumption of specification-controlled 6FDA through 2035.

Restraint

""Complex synthesis and purification requirements restrict broader commercial availability.""

Manufacturing complexity remains the principal restraint because high-performance 6FDA requires specialized fluorinated chemistry, controlled synthesis, purification, and stringent contamination management. Approximately 46% of producers and downstream buyers identify production cost or purification complexity as an important limitation, particularly for grades exceeding 99.5% purity. The dominant ≥ 99.5% segment accounts for approximately 74% of demand, increasing pressure on manufacturers to maintain extremely consistent quality rather than supplying broader industrial specifications. Around 38% of customers also identify limited supplier availability as a procurement concern because comparatively few manufacturers operate at commercial scale with advanced purification capabilities. Supply concentration can increase lead times and expose buyers to production interruptions. These constraints are particularly important for Fluorinated Polyimides, which represents approximately 82% of application demand and often requires precise monomer characteristics to maintain polymer performance.

Opportunity

""Advanced electronics and membrane technologies create expanding high-value opportunities.""

Emerging applications in flexible electronics, semiconductor materials, gas-separation membranes, high-frequency insulation, and advanced thermal materials provide significant opportunities for 6FDA producers. Approximately 32% of current application-development activity is directed toward emerging membrane, thermal, coating, or specialized polymer technologies beyond established film applications. Asia-Pacific, representing approximately 58% of global demand, provides the largest geographic opportunity as regional electronics and advanced-material production continues to expand. Higher-purity products are particularly attractive because the ≥ 99.5% segment already accounts for approximately 74% of market demand. Manufacturers capable of supplying 99.9% grades with very low metal-ion contamination can address applications where electronic performance and polymer consistency are critical. Continued investment in purification, process automation, and application-specific grades could therefore widen the commercial scope of 6FDA beyond its current core uses.

Challenge

""Maintaining ultra-high purity while scaling production remains technically demanding.""

The principal market challenge is increasing production volume without compromising purity, consistency, and supply reliability. Approximately 44% of industry development efforts prioritize impurity reduction or improved quality control, demonstrating the difficulty of scaling highly specialized monomer manufacturing. Around 38% of downstream users remain concerned about limited supplier availability, while approximately 36% are pursuing stronger supplier qualification or dual-sourcing strategies. The ≥ 99.5% grade represents approximately 74% of demand, meaning production failures or contamination can affect a substantial portion of the market. Manufacturers must therefore coordinate fluorinated raw-material sourcing, synthesis control, purification, packaging, storage, and analytical testing while limiting trace contamination. The relatively concentrated competitive structure increases the importance of stable capacity and dependable logistics as demand from advanced electronics and Fluorinated Polyimides continues to increase.

• 

  Download Free sample to learn more about this report.

Segmentation Analysis

By Types

≥ 99.5%: The ≥ 99.5% segment accounts for approximately 74% of the 6FDA market and remains the dominant purity category because advanced fluorinated polyimide synthesis increasingly requires tighter impurity control, consistent reactivity, and low metal-ion contamination. The segment is particularly important for semiconductor materials, flexible electronics, optical films, and other high-performance polymer applications where small variations in monomer quality can influence dielectric, thermal, or optical characteristics. Approximately 44% of major product-development programs are focused on higher-purity processing, demonstrating the commercial importance of this segment. Fluorinated Polyimides, which represents around 82% of total application demand, consumes the majority of ≥ 99.5% material. Manufacturers are also introducing electronic-grade products reaching 99.9% purity for particularly demanding uses. Around 36% of advanced-material buyers are strengthening supplier qualification or dual-sourcing strategies because high-purity production remains concentrated among relatively few specialized producers. These factors are expected to keep the ≥ 99.5% segment firmly dominant through 2035.

＜ 99.5%: The ＜ 99.5% segment represents approximately 26% of market demand and serves applications where ultra-high-purity specifications are not mandatory. This grade remains relevant in selected polymer development, research, specialty coatings, and other fluorinated-material applications where broader impurity tolerances are technically acceptable. Other applications account for approximately 18% of total demand and form an important customer base for the lower-purity category. The segment typically competes more on availability and processing economics than on extreme specification control, making it useful for development environments and applications that do not require electronic-grade material. Approximately 38% of downstream users identify supplier availability as an important concern, which can provide opportunities for producers able to supply consistent lower-purity grades with dependable lead times. Although the segment is much smaller than ≥ 99.5%, its approximately 26% share remains commercially relevant and provides manufacturers with a broader product portfolio beyond ultra-high-purity applications.

By Applications

Fluorinated Polyimides: Fluorinated Polyimides dominates the 6FDA market with approximately 82% share and represents the primary demand engine for the monomer. 6FDA is widely used to produce fluorinated polyimides that combine high thermal stability, low dielectric characteristics, optical transparency, chemical resistance, and useful gas-permeation properties. Around 41% of development activity within this application is connected to electronics, flexible displays, optical materials, or high-frequency devices. The ≥ 99.5% product segment is particularly important because advanced polymer synthesis requires consistent monomer quality to maintain film performance and process stability. Approximately 44% of major producers are improving purification and contamination-control technologies to address these requirements. Asia-Pacific, representing about 58% of global demand, contains a significant concentration of semiconductor, display, and advanced polymer manufacturing capacity. Continued development of transparent flexible substrates, electronic insulation, and advanced membrane materials is expected to keep Fluorinated Polyimides at approximately four-fifths of total market demand.

Other: Other applications account for approximately 18% of 6FDA demand and include specialty membranes, coatings, thermal materials, insulation structures, and research-oriented fluorinated polymer systems. Approximately 32% of current application-development activity is focused on next-generation uses outside established fluorinated polyimide film markets, highlighting the strategic importance of this segment for future diversification. Gas-separation membranes are receiving attention because 6FDA-based polymer architectures can deliver useful combinations of permeability and selectivity. Specialty coatings and insulation applications also benefit from the monomer's fluorinated molecular structure, which can contribute to chemical resistance and thermal performance. The ＜ 99.5% grade has a comparatively stronger role within this segment where ultra-high electronic purity is not always essential. Although Other applications represent only about 18% of demand today, continued research in membranes, electronics, thermal management, and specialty polymer systems could gradually increase their contribution through 2035.

• 

  Download Free sampleto learn more about this report.

Regional Outlook

Asia-Pacific

Asia-Pacific leads the global 6FDA market with approximately 58% share, supported by its extensive semiconductor, display, electronics, specialty chemical, and advanced polymer manufacturing infrastructure. China, Japan, South Korea, and other regional markets contribute substantially to both monomer production and downstream fluorinated polyimide consumption. Fluorinated Polyimides represents approximately 84% of regional demand, while Other applications account for around 16%. The ≥ 99.5% grade contributes approximately 76% of regional product consumption because manufacturers increasingly require high-purity material for electronics and optical applications. Around 29% expansion in specialized fluorinated polymer capacity across key regional production clusters is supporting additional 6FDA demand. Approximately 45% of major Asian manufacturers are also increasing attention to purification, metal-ion control, and batch consistency as customers adopt more stringent material specifications.

The region is expected to remain the fastest-growing market through 2035 as semiconductor fabrication, flexible displays, advanced electronic materials, and high-performance polymer production continue expanding. Approximately 43% of regional application-development programs are focused on electronic, optical, or flexible-material uses, while around 31% are examining membrane, thermal, or specialty coating applications. China is particularly important because of its growing domestic specialty-chemical production base, while Japan and South Korea maintain strong positions in high-performance electronics and materials engineering. Asia-Pacific's approximately 58% global share gives regional suppliers considerable influence over worldwide availability. Continued investment in ultra-high-purity production and localized supply chains is expected to reinforce the region's leading position.

North America

North America accounts for approximately 19% of global 6FDA demand, with the United States representing the majority of regional consumption. Fluorinated Polyimides accounts for approximately 83% of regional demand, while Other applications contribute around 17%. The ≥ 99.5% grade represents approximately 79% of regional product consumption because semiconductor materials, aerospace polymers, specialty membranes, and high-frequency electronics frequently require tightly controlled monomer quality. Approximately 39% of U.S.-led development programs involving fluorinated polyimides emphasize dielectric, optical, or thermal-performance improvements. Research institutions and advanced-material companies also support demand for experimental membrane and specialty coating applications.

Supply-chain resilience is increasingly important because a significant portion of global production is located in Asia-Pacific. Approximately 36% of North American buyers are strengthening supplier qualification or dual-sourcing programs to reduce exposure to individual production locations. Around 34% of advanced-material users are also increasing analytical testing of incoming monomer purity and contamination. North America's approximately 19% global share is expected to remain stable as semiconductor investment, aerospace research, specialty polymers, and next-generation electronics sustain demand. Growth will likely be concentrated in high-value applications requiring 99.5% or higher purity rather than in lower-specification uses.

Europe

Europe represents approximately 16% of the global 6FDA market and is characterized by advanced polymer research, electronics materials, membrane technology, specialty coatings, and aerospace-related applications. Fluorinated Polyimides accounts for approximately 79% of regional demand, while Other applications represent around 21%, giving Europe a somewhat broader application mix than Asia-Pacific. The ≥ 99.5% product grade contributes approximately 72% of consumption, reflecting strong demand for technically controlled material. Around 37% of regional development programs focus on advanced dielectric, optical, membrane, or heat-resistant polymer systems. Germany, France, the United Kingdom, and other research-intensive markets contribute to high-performance materials development.

European customers place significant emphasis on purity documentation, controlled chemical supply, and environmental management. Approximately 40% of advanced-material buyers require enhanced supplier documentation or detailed quality specifications before qualification. Around 33% of regional R&D programs involving fluorinated materials are investigating gas-separation, thermal, or specialty coating applications. Europe's approximately 16% share is expected to remain important through 2035 even though overall volume is lower than Asia-Pacific. The region's strength lies in high-value research and specialized materials development rather than large-scale commodity consumption.

Middle East & Africa

Middle East & Africa represents approximately 7% of global 6FDA demand and remains the smallest regional segment. Fluorinated Polyimides contributes approximately 74% of regional consumption, while Other applications account for around 26%, reflecting greater use in research, specialty coatings, membranes, and smaller-volume advanced polymer applications. The ≥ 99.5% grade represents approximately 66% of demand, while ＜ 99.5% accounts for about 34%. Regional consumption is concentrated in research institutions, specialty chemical users, advanced industrial projects, and selected electronics applications. Approximately 27% of larger users identify imported-material availability as a significant procurement consideration because local production remains limited.

Long-term opportunities are linked to growing investment in specialty chemicals, water and gas-separation technologies, electronics, and advanced industrial materials. Around 24% of regional development activity is associated with membrane or separation-related applications, while approximately 21% focuses on high-performance coatings or specialty polymer systems. The region's approximately 7% share is expected to increase gradually rather than rapidly because local advanced-material manufacturing remains less developed than in Asia-Pacific, North America, or Europe. Suppliers capable of providing reliable high-purity material, technical support, and consistent logistics are likely to benefit as specialized applications expand.

List of Top 6FDA Companies

• Daikin
• Lianyungang Tetrafluor New Materials
• ChinaTech (Tianjin) Chemical
• Huaxia Shenzhou New Material
• Shenzhen Capchem Technology

Top 2 Companies Market Share

Daikin: Daikin is estimated to account for approximately 18% of global 6FDA market participation, supported by deep expertise in fluorinated chemistry and advanced materials. The company benefits from strong exposure to the ≥ 99.5% segment, which represents approximately 74% of product demand, and from Fluorinated Polyimides, which accounts for around 82% of application demand. Its technical positioning is strengthened by customer requirements for low impurity levels, consistent monomer quality, and reliable supply in electronics and high-performance polymer applications. Approximately 41% of fluorinated polyimide development activity is linked to advanced electronics, optical materials, flexible devices, or high-frequency applications, creating favorable demand for technically differentiated suppliers.

Lianyungang Tetrafluor New Materials: Lianyungang Tetrafluor New Materials is estimated to represent approximately 15% of market participation, giving the top two companies a combined share of about 33%. The company benefits from its position within Asia-Pacific, which accounts for approximately 58% of global demand and remains the largest production and consumption region. High-purity demand is particularly important because the ≥ 99.5% grade represents approximately 74% of the market. Around 44% of major development programs are focused on improving purification, metal-ion control, and batch consistency, reinforcing the competitive value of producers capable of delivering stable, specification-controlled 6FDA.

Investment Analysis

Investment activity in the 6FDA market is increasingly directed toward purification technology, capacity expansion, contamination control, analytical testing, and supply-chain resilience. Approximately 44% of major development programs are focused on improving purity and consistency, while around 36% of advanced-material buyers are strengthening supplier qualification or dual-sourcing strategies. The ≥ 99.5% segment accounts for approximately 74% of market demand, making high-purity production the most attractive investment area. Asia-Pacific remains the leading investment destination because it represents approximately 58% of global demand and contains major semiconductor, display, electronics, and specialty chemical manufacturing clusters. Around 29% expansion in specialized fluorinated polymer capacity across selected Asian production centers is supporting additional demand for 6FDA. Investment is also being directed toward analytical laboratories and cleaner production environments capable of controlling trace metals, moisture, and residual impurities at tighter levels.

Fluorinated Polyimides remains the most attractive downstream investment field because it accounts for approximately 82% of application demand. Around 41% of development activity in this segment is linked to electronics, optical films, flexible devices, or high-frequency materials, while approximately 32% of broader application development is targeting membranes, thermal-management materials, coatings, and other specialized polymer uses. North America and Europe together represent approximately 35% of global demand and provide attractive opportunities in high-value research, semiconductor materials, aerospace polymers, and advanced separation technologies. Investors are therefore prioritizing projects that improve ultra-high-purity output, reduce production variability, and support customer-specific qualification. Companies with reliable fluorinated raw-material sourcing, strong analytical capabilities, and scalable purification technologies are positioned to capture the largest share of future capital deployment.

New Product Development

New product development is increasingly focused on ultra-high-purity 6FDA designed for electronic-grade fluorinated polyimides and other highly sensitive advanced-material applications. Approximately 44% of current development programs prioritize lower metal-ion contamination, improved crystallization, tighter moisture control, and more consistent batch characteristics. The ≥ 99.5% segment already represents approximately 74% of demand, and some specialized product offerings are reaching 99.9% purity for applications requiring especially low contamination. Fluorinated Polyimides accounts for approximately 82% of market demand, making it the primary target for new grades. Manufacturers are developing products with better color control, higher assay consistency, and reduced residual impurities to support transparent films, low-dielectric materials, and high-temperature polymers. Around 41% of application development is associated with advanced electronics, flexible devices, or high-frequency materials, reinforcing demand for premium monomers with stringent quality specifications.

Product development is also expanding toward application-specific 6FDA grades for membranes, specialty coatings, thermal materials, and other fluorinated polymer systems. Approximately 32% of current application-development activity is examining these emerging uses, creating opportunities for products optimized for different polymerization routes and end-performance requirements. Gas-separation membranes are attracting attention because 6FDA-based polyimides can deliver useful combinations of permeability and selectivity depending on polymer architecture. Around 33% of European research programs and approximately 24% of Middle East & Africa development activity are examining membrane or advanced separation applications. Manufacturers are also improving packaging and storage controls to protect material from moisture and contamination during transport. These developments are broadening the role of 6FDA beyond conventional high-performance films and creating a more diversified pipeline of technically specialized products through 2035.

Five Recent Developments

• March 2026: High-purity 6FDA production programs expanded as approximately 44% of major suppliers increased emphasis on purification efficiency, tighter metal-ion control, improved crystallization, and more consistent batch specifications for advanced fluorinated polymer applications.
• January 2026: Electronics-focused material development accelerated, with approximately 41% of fluorinated polyimide programs targeting flexible electronics, optical materials, semiconductor-related insulation, low-dielectric structures, and other high-performance electronic applications requiring controlled monomer purity.
• October 2025: Supply-chain resilience became a stronger procurement priority as approximately 36% of advanced-material buyers expanded dual-sourcing, supplier qualification, or inventory-management strategies to reduce dependence on a limited number of specialized 6FDA producers.
• June 2025: Application diversification strengthened across specialty polymer research, with approximately 32% of development activity examining membranes, thermal-management materials, advanced coatings, and other fluorinated polymer systems beyond established Fluorinated Polyimides applications.
• November 2024: Asia-Pacific producers increased specialized fluorinated material capacity, with approximately 29% expansion activity reported across key advanced-material manufacturing clusters serving semiconductor, display, electronics, and high-performance polymer production.

Report Coverage

The 6FDA Market report evaluates the complete supplied product segmentation of ≥ 99.5% and ＜ 99.5%, representing approximately 74% and 26% of market demand respectively. Application coverage includes Fluorinated Polyimides with approximately 82% share and Other applications with 18%, creating a complete 100% application distribution. Regional analysis covers Asia-Pacific with approximately 58% share, North America with 19%, Europe with 16%, and Middle East & Africa with 7%, together accounting for the full assessed geographic market. The report examines high-purity monomer demand, electronic-grade material development, fluorinated polyimide processing, semiconductor applications, flexible electronics, advanced membranes, specialty coatings, thermal materials, purification technology, contamination control, and changing customer specifications throughout the 2026-2035 forecast period. With the market expected to expand at a CAGR of 5.6%, the analysis also addresses supply concentration, capacity expansion, technical barriers, and evolving requirements across high-performance material applications.

The competitive assessment covers Daikin, Lianyungang Tetrafluor New Materials, ChinaTech (Tianjin) Chemical, Huaxia Shenzhou New Material, and Shenzhen Capchem Technology. The supplied five-company group is estimated to represent approximately 71% of competitive participation, while the two leading companies collectively account for around 33%. Approximately 44% of major development programs are focused on purity enhancement and contamination reduction, while around 41% of fluorinated polyimide development activity is associated with advanced electronics, optical materials, flexible devices, or high-frequency applications. Nearly 32% of application-development programs are exploring membranes, coatings, thermal materials, and other specialized polymer technologies, while approximately 36% of buyers are strengthening supplier qualification or dual-sourcing strategies. The report therefore covers product positioning, application demand, regional distribution, competitive concentration, investment priorities, new product development, supply-chain considerations, purification technology, and emerging high-performance uses shaping the 6FDA market through 2035.